The mTOR kinase is the central component of a pathway controls growth in eukaryotes and is deregulated in common human diseases like cancer and diabetes. Within cells mTOR exists within two distinct protein complexes, mTOR Complex 1 (mTORC1) and 2 (mTORC2). mTORC1 contains mTOR, mLST8/G2L, raptor, and PRAS40, is partially sensitive to rapamycin, and controls cell size through translational regulators like S6K1 and 4E-BP1. mTORC2 also contains mTOR and mLST8, but, instead of raptor and PRAS40, it contains rictor, mSin1, and protor. We know less about mTORC2 than mTORC1 but it is now accepted that mTORC2 is an activating kinase for Akt/PKB and SGK and therefore part of the PI3K pathway that controls cell survival, proliferation, and metabolism. Recently, we discovered that DEPTOR, a protein of previously unknown function, interacts directly with mTOR and inhibits mTORC1 and mTORC2 signaling in cells through unclear mechanisms. DEPTOR protein levels are highly regulated by the same growth stimuli and stresses that regulate mTORC1 and mTORC2. Overexpression of DEPTOR inhibits mTORC1 signaling, which, in turn, activates the PI3K pathway by suppressing a known inhibitory feedback from mTORC1 to PI3K. In cancers like Multiple Myeloma, DEPTOR is highly overexpressed and the resulting activation of PI3K is a new mechanism for promoting cell survival. We propose to: (1) determine how DEPTOR inhibits mTORC1 and mTORC2 signaling;(2) identify and characterize the molecular mechanisms that regulate the expression level of DEPTOR;and (3) determine the in vivo role of DEPTOR in the mTORC1 and mTORC1 pathways and in controlling liver growth and function. We will accomplish our goals with a multi-disciplinary approach that uses the tools of biochemistry, molecular biology, proteomics, high-throughput RNAi screening, and engineered mouse models. Our results are likely to have important consequences for our understanding of the clinically important mTOR pathway and the signaling mechanisms we uncover may serve in the future as targets for drug development.

Public Health Relevance

Growth is the process through which cells and organisms accumulate mass and increase in size. Over the last few years it has become clear that this basic biological process is deregulated in common human diseases like cancer and diabetes. We have recently discovered a protein called DEPTOR that our preliminary evidence indicates is an important new regulator of growth. DEPTOR is part of a network within cells called the 'mTOR pathway'that is known to be a major growth regulator. We propose to elucidate the molecular mechanisms through which DEPTOR regulates the mTOR pathway in response to growth factors like insulin, and to use engineered mouse models to understand how DEPTOR regulates organ growth in vivo. The overarching goal of our proposed work is to increase the molecular understanding of the mTOR pathway so as to enable the medical community to rationally exploit the mTOR pathway in the treatment of disease. Our work will also elucidate molecular mechanisms that are deranged in human cancers and thus may serve as targets for future drug development.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Method to Extend Research in Time (MERIT) Award (R37)
Project #
Application #
Study Section
Cellular Signaling and Regulatory Systems Study Section (CSRS)
Program Officer
Mallia, Conrad M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Whitehead Institute for Biomedical Research
United States
Zip Code
Soliman, Mohamed A; Abdel Rahman, Anas M; Lamming, Dudley W et al. (2014) The adaptor protein p66Shc inhibits mTOR-dependent anabolic metabolism. Sci Signal 7:ra17
Shaul, Yoav D; Freinkman, Elizaveta; Comb, William C et al. (2014) Dihydropyrimidine accumulation is required for the epithelial-mesenchymal transition. Cell 158:1094-109
Grabiner, Brian C; Nardi, Valentina; Birsoy, K?vanc et al. (2014) A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity. Cancer Discov 4:554-63
Chantranupong, Lynne; Wolfson, Rachel L; Orozco, Jose M et al. (2014) The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1. Cell Rep 9:1-8
Chen, Walter W; Birsoy, K?vanç; Mihaylova, Maria M et al. (2014) Inhibition of ATPIF1 ameliorates severe mitochondrial respiratory chain dysfunction in mammalian cells. Cell Rep 7:27-34
Bar-Peled, Liron; Sabatini, David M (2014) Regulation of mTORC1 by amino acids. Trends Cell Biol 24:400-6
Efeyan, Alejo; Schweitzer, Lawrence D; Bilate, Angelina M et al. (2014) RagA, but not RagB, is essential for embryonic development and adult mice. Dev Cell 29:321-9
Mihaylova, Maria M; Sabatini, David M; Yilmaz, Ömer H (2014) Dietary and metabolic control of stem cell function in physiology and cancer. Cell Stem Cell 14:292-305
Bar-Peled, Liron; Chantranupong, Lynne; Cherniack, Andrew D et al. (2013) A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 340:1100-6
Byles, Vanessa; Covarrubias, Anthony J; Ben-Sahra, Issam et al. (2013) The TSC-mTOR pathway regulates macrophage polarization. Nat Commun 4:2834

Showing the most recent 10 out of 23 publications